HS-25

· Zhejiang Hisun Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HS-25, covering 2015-01-06 to 2018-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases [Phase 3]

See pricing